255 related articles for article (PubMed ID: 6121405)
1. Bone marrow transplantation across major histocompatibility barriers in mice. II. T cell requirement for engraftment in total lymphoid irradiation-conditioned recipients.
Vallera DA; Soderling CC; Carlson GJ; Kersey JH
Transplantation; 1982 Mar; 33(3):243-8. PubMed ID: 6121405
[TBL] [Abstract][Full Text] [Related]
2. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
Soderling CC; Song CW; Blazar BR; Vallera DA
J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
Vallera DA; Soderling CC; Kersey JH
J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
[TBL] [Abstract][Full Text] [Related]
4. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells.
Lan F; Zeng D; Higuchi M; Higgins JP; Strober S
Biol Blood Marrow Transplant; 2003 Jun; 9(6):355-63. PubMed ID: 12813443
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone.
Vallera DA; Soderling CC; Carlson GJ; Kersey JH
Transplantation; 1981 Mar; 31(3):218-22. PubMed ID: 7015617
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-host reactivity and graft-versus-leukemia effect in murine allogeneic bone marrow chimeras conditioned with total body irradiation or total lymphoid irradiation.
Salam A; Waer M
Transplantation; 1996 Mar; 61(5):826-30. PubMed ID: 8607190
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation across major histocompatibility barriers in mice. IV. Graft-versus-host disease in TLI-conditioned mice.
Vallera DA; Filipovich A; Soderling CC; Kersey JH
Clin Immunol Immunopathol; 1982 May; 23(2):437-47. PubMed ID: 7049469
[No Abstract] [Full Text] [Related]
8. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
9. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
Martin PJ
J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation.
Slavin S; Fuks Z; Kaplan HS; Strober S
J Exp Med; 1978 Apr; 147(4):963-72. PubMed ID: 25942
[TBL] [Abstract][Full Text] [Related]
11. Absence of a facilitory role for NK 1.1-positive donor cells in engraftment across a major histocompatibility barrier in mice.
Blazar BR; Soderling CC; Koo GC; Vallera DA
Transplantation; 1988 May; 45(5):876-83. PubMed ID: 2897141
[TBL] [Abstract][Full Text] [Related]
12. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.
Soiffer RJ; Mauch P; Tarbell NJ; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Murrey CI; Coral F; Bosserman L
Bone Marrow Transplant; 1991 Jan; 7(1):23-33. PubMed ID: 2043874
[TBL] [Abstract][Full Text] [Related]
13. Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation.
Luznik L; Engstrom LW; Iannone R; Fuchs EJ
Biol Blood Marrow Transplant; 2002; 8(3):131-8. PubMed ID: 11939602
[TBL] [Abstract][Full Text] [Related]
14. Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide.
Luznik L; Jalla S; Engstrom LW; Iannone R; Fuchs EJ
Blood; 2001 Dec; 98(12):3456-64. PubMed ID: 11719388
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts.
Blazar BR; Taylor PA; Smith S; Vallera DA
Blood; 1995 Feb; 85(3):842-51. PubMed ID: 7833486
[TBL] [Abstract][Full Text] [Related]
16. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
Neipp M; Gammie JS; Exner BG; Li S; Chambers WH; Pham SM; Ildstad ST
Transplantation; 1999 Aug; 68(3):369-78. PubMed ID: 10459540
[TBL] [Abstract][Full Text] [Related]
17. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):477-85. PubMed ID: 8610364
[TBL] [Abstract][Full Text] [Related]
18. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
19. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
[TBL] [Abstract][Full Text] [Related]
20. Functional clonal deletion versus suppressor cell-induced transplantation tolerance in chimeras prepared with a short course of total-lymphoid irradiation.
Slavin S; Morecki S; Weigensberg M; Bar S; Weiss L
Transplantation; 1986 Jun; 41(6):680-7. PubMed ID: 2940736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
